News

Abbott and Surmodics proclaimed having forayed into an agreement wherein Abbott will possess exclusive commercialization rights for Surmodic's Surveil drug-coated balloon to treat the…
Read More...

Longeveron asserted that its revolutionary Clinical Trial initiated to treat infants with Hypoplastic Left Heart Syndrome as the first patient received the treatment using the company's…
Read More...

Medical device company reinventing venous access using proprietary material technology designed to reduce thrombus accumulation, Access Vascular asserted that the Company has sought …
Read More...

Eli Lilly and Company proclaimed that the USFood and Drug Administration has sanctioned Verzenio (abemaciclib) in combination with an aromatase inhibitor (AI) as initial endocrine-based…
Read More...

PharmaCyte Biotech aiming to develop targeted cellular therapies for Cancer and diabetes using its signature  live-cell encapsulation technology, Cell-in-a-Box, announced that its…
Read More...

Vertex Pharmaceuticals asserted that Reshma Kewalramani, MD., has been appointed Chief Medical Officer and Executive Vice President, Global Medicines Development and Medical Affairs,…
Read More...

Shionogi asserted that the NDA for lusutrombopag (S-888711), an investigational, once-daily, orally administered , small molecule thrombopoietin (TPO) receptor agonist, has been…
Read More...

Pharmaceutical company, Neumentum committed to transforming the way acute and chronic pain are treated-without  opioids asserted the confirmation of Type B meeting with the U.S FDA…
Read More...

Therapy combinations, Biomarkers and the challenge of prayer coverage for CAR T-cell therapy are the topics selected for this year's special tissue on immuno-oncology in  Evidence-Based…
Read More...

EpimAb Biotherapeutics which is essentially a biologics company based in Shanghai, China emphasizing on developing a portfolio of bispecific antibodies declared the appointment of Bin…
Read More...

Genomic Health asserted the U.S commercial launch of  Oncotype DX AR-V7 Nucleus Detect test. The Oncotype DX AR-V7 Nucleus Detect test was developed by Epic Sciences to help prolong the…
Read More...

The Journal of the American Osteopathic Association signified inefficiency of Vitamin D that can't be metabolized owing to low Magnesium Levels that implies Vitamin D remains stored and…
Read More...

CE Mark approval was sought for EPD's Cardiac Mapping and Navigation System. The system helps electrophysiologists navigate the heart by generating a succinct 3D Map while imaging and…
Read More...

Leading Science and technology company, Merck announced that the Argentinian Administration of Medicines, Food and Medical Technology has sanctioned the registration of MAVENCLAD …
Read More...

Atrium Health's Levine Children's Hospital proved to be a new trial site to test a new medicine for children that can regulate and stabilize their blood pressure in fatal circumstances.…
Read More...

Genomics England and Lantern Pharma that emphasizes on precision oncology incorporating Artificial intelligence asserted that Lantern will associate with Genomics England's Discovery…
Read More...

Amgen asserted that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion to expand the current indication for…
Read More...

Jazz Pharmaceuticals asserted the enrollment of patients in a Phase 2 Clinical Trial evaluating the efficacy and safety of defibrotide for the prevention of acute…
Read More...

Stephen Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine on National Toxicology Program draft report on Bisphenol A stating that "We base our regulatory decisions on…
Read More...

Leading innovator in  treatments for atrial fibrillation (Afib), AtriCure and left atrial appendage management (LAAM) announced the rolling out of AtriClip FLEX•V Left Atrial Appendage…
Read More...